Canaccord Genuity Starts BioNTech (BNTX) at Buy
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $97.55 +3.86%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Canaccord Genuity analyst Arlinda Lee initiates coverage on BioNTech (NASDAQ: BNTX) with a Buy rating and a price target of $22.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $17.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Canada Starts Apotex Health Corp (APTX:CN) at Buy
- Barclays Starts Forbright Inc (FRBT) at Overweight
- Stifel Starts WhiteHawk Minerals Corp (WHK) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
